Early Convalescent Plasma Therapy and Mortality among US Veterans Hospitalized with Non-Severe COVID-19: An Observational Analysis Emulating a Target Trial.

Author(s): Cho K, Keithly SC, Kurgansky KE, Madenci AL, Gerlovin H, Wellman HM, Doubleday A, Thomas ER, Park Y, Ho YA, Sugimoto JD, Moore KP, Peterson AC, Hoag C, Gupta K, Jeans K, Klote M, Ramoni R, Huang GD, Casas JP, Gagnon DR, Hernán MA, Smith NL, Gaziano JMJournal: J Infect DisPMID: 34153099 August 2021
Early convalescent plasma transfusion may reduce mortality in patients with non-severe coronavirus disease 2019 (COVID-19).

ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.

Author(s): Pérez-Gómez B, Pastor-Barriuso R, Pérez-Olmeda M, Hernán MA, Oteo-Iglesias J, Fernández de Larrea N, Fernández-García A, Martín M, Fernández-Navarro P, Cruz I, Sanmartín JL, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R, Pollán M, ENE-COVID Study Group.Journal: J Clin EpidemiolPMID: 34126206 August 2021
To characterize asymptomatic SARS-CoV-2 infections and develop a symptom-based risk score useful in primary healthcare.